Literature DB >> 4029015

Biliary concentrations of temocillin.

F Spelsberg, A Bauernfeind, W Wiest, P Hanser.   

Abstract

Serum and bile concentrations of temocillin were measured after intravenous administration of 1g twice daily to 16 patients with biliary tract infections. The concentration of temocillin in the bile showed high inter-individual variations; however, in patients drug concentrations were attained which were considerably higher than the minimum inhibitory concentrations of the biliary tract pathogens identified throughout the study period. All the patients admitted to the study were treated successfully by temocillin, with the tolerance of the drug being very good, and no side effects or drug-related deteriorations of laboratory data being reported.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029015     DOI: 10.2165/00003495-198500295-00026

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  4 in total

1.  Antibiotics in bile.

Authors:  M Thomas
Journal:  J Antimicrob Chemother       Date:  1983-11       Impact factor: 5.790

2.  Temocillin bile levels.

Authors:  M Uwaydah; F Najjar; S Vartivarian; H Harakeh
Journal:  J Antimicrob Chemother       Date:  1984-08       Impact factor: 5.790

3.  Efficacy of antibiotics in bacteriobilia.

Authors:  H Wacha; E B Helm
Journal:  J Antimicrob Chemother       Date:  1982-01       Impact factor: 5.790

4.  [Microbiological studies with the new penicillin BRL 17421 (temocillin)].

Authors:  R Malottke; J Potel
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

  4 in total
  2 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Temocillin.

Authors:  Kevin Alexandre; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

2.  Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion.

Authors:  Perrin Ngougni Pokem; Xavier Wittebole; Christine Collienne; Hector Rodriguez-Villalobos; Paul M Tulkens; Laure Elens; Françoise Van Bambeke; Pierre-François Laterre
Journal:  Antibiotics (Basel)       Date:  2022-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.